Patent · US Active

Compositions comprising mesenchymal stem cell-derived fibroblasts

US9382514B2 · kind B2 · utility

11Cited by
11References
18Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 17, 2009
Grant dateJul 5, 2016
Priority date
Expiry dateOct 5, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2501/15
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Methods and compositions are provided for the differentiation and characterization of mammalian fibroblast from mesenchymal stem cells. The methods of the invention provide a means to obtain mesenchymal stem cell-derived fibroblast populations, e.g., seeded on a scaffold, which may be used in wound healing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.